...
首页> 外文期刊>Clinical Endocrinology >Molecular screening of the TSH receptor (TSHR) and thyroid peroxidase (TPO) genes in Korean patients with nonsyndromic congenital hypothyroidism.
【24h】

Molecular screening of the TSH receptor (TSHR) and thyroid peroxidase (TPO) genes in Korean patients with nonsyndromic congenital hypothyroidism.

机译:非先天性先天性甲状腺功能减退症的韩国患者中TSH受体(TSHR)和甲状腺过氧化物酶(TPO)基因的分子筛查。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To investigate thyroid-stimulating hormone receptor (TSHR) and thyroid peroxidase (TPO) mutations in Korean patients with primary congenital hypothyroidism (CH). CONTEXT: Congenital hypothyroidism is a common genetic disorder in which the majority of mutations occur in the TSHR and TPO genes. DESIGN: We examined the frequencies of TSHR and TPO mutations among Korean patients with primary CH. Furthermore, we explored the relationships between imaging findings and mutation status. PATIENTS: A total of 193 paediatric patients with nonsyndromic CH were enrolled in the present study. MEASUREMENTS: Patients with decreased (99m) Tc uptake were screened for TSHR mutations using Sanger sequencing, and those with increased uptake were screened for TPO mutations. The relationships between scintigraphic and ultrasonographic findings and mutation status were analysed. RESULTS: Thirteen (16.5%) of 79 patients with decreased (99m) Tc uptake were found to harbour TSHR mutations including G132R, G245S, R450H, R519C and F525S. The R450H mutation was present in 13 (72.2%) of 18 disease alleles. Seven (10.3%) of 68 patients with increased (99m) Tc uptake harboured TPO mutations including R189Q, K439E, G493S, C808LfsX72, A863T, R875Hfs and P883S. The TSHR and TPO mutations were observed only in patients with normal to slightly enlarged thyroid glands. CONCLUSIONS: This study identified underlying TSHR and TPO mutations in Korean patients with CH and revealed a possible relationship between imaging findings and mutation status. In addition, the low rate of mutation positivity suggests significant genetic heterogeneity of CH in the Korean population.
机译:目的:调查韩国原发性先天性甲状腺功能减退症(CH)患者的促甲状腺激素受体(TSHR)和甲状腺过氧化物酶(TPO)突变。背景:先天性甲状腺功能减退症是一种常见的遗传疾病,其中大多数突变发生在TSHR和TPO基因中。设计:我们检查了韩国原发性CH患者中TSHR和TPO突变的频率。此外,我们探索了影像学发现与突变状态之间的关系。患者:本研究共纳入193例非综合征性CH患儿。测量:使用Sanger测序对Tc吸收减少(99m)的患者进行TSHR突变​​筛查,对Tc吸收增加的患者进行TPO突变筛查。分析了闪烁体和超声检查结果与突变状态之间的关系。结果:发现79例Tc吸收减少(99m)的患者中有13例(16.5%)具有TSHR突变​​,包括G132R,G245S,R450H,R519C和F525S。 R450H突变存在于18个疾病等位基因中的13个(72.2%)。 68位Tc摄取增加(99m)的患者中有7位(10.3%)带有TPO突变,包括R189Q,K439E,G493S,C808LfsX72,A863T,R875Hfs和P883S。仅在甲状腺正常至轻度增大的患者中观察到TSHR和TPO突变。结论:这项研究确定了韩国CH患者的基本TSHR和TPO突变,并揭示了影像学表现与突变状态之间的可能关系。另外,低的突变阳性率表明CH在韩国人群中具有显着的遗传异质性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号